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G E N E T I C S
Histone deacetylases 1 and 2 silence cryptic 
transcription to promote mitochondrial function  
during cardiogenesis
Zachary J. Milstone1,2, Sherin Saheera1,2, Lauren M. Bourke1,2, Tomer Shpilka3,  
Cole M. Haynes3, Chinmay M. Trivedi1,2,3,4*
Cryptic transcription occurs widely across the eukaryotic genome; however, its regulation during vertebrate 
development is not understood. Here, we show that two class I histone deacetylases, Hdac1 and Hdac2, silence 
cryptic transcription to promote mitochondrial function in developing murine hearts. Mice lacking Hdac1 and 
Hdac2 in heart exhibit defective developmental switch from anaerobic to mitochondrial oxidative phosphorylation 
(OXPHOS), severe defects in mitochondrial mass, mitochondrial function, and complete embryonic lethality. Hdac1/
Hdac2 promotes the transition to OXPHOS by enforcing transcriptional fidelity of metabolic gene programs. 
Mechanistically, Hdac1/Hdac2 deacetylates histone residues including H3K23, H3K14, and H4K16 to suppress 
cryptic transcriptional initiation within the coding regions of actively transcribed metabolic genes. Thus, 
Hdac1/2-mediated epigenetic silencing of cryptic transcription is essential for mitochondrial function during early 
vertebrate development.
INTRODUCTION
The mammalian heart forms early during development, requiring 
constant energy to maintain its critical pumping action. During early 
cardiac development, cardiomyocytes switch energy production from 
anaerobic pathways to mitochondrial oxidative phosphorylation 
(OXPHOS) (1). Multiple studies link defective developmental energy 
generation and congenital heart disease (CHD), with almost every 
metabolic disruption associated with cardiac symptoms (2). Although 
recent advances identified the transition to OXPHOS as a checkpoint 
and potential origin for metabolic CHD, the molecular basis for this 
developmental metabolic transition remains elusive (1, 3, 4). In adult 
cardiomyopathies and metabolic syndrome, pathologic reversal of 
the anaerobic to OXPHOS switch occurs, suggesting epigenetic reg-
ulation (5). Concordantly, intracellular metabolic transitions, in both 
development and disease, alter a myriad of lysine residues on histone 
tails, influencing gene expression (6). Emerging data highlight that 
intracellular metabolites modulate activity of histone deacetylases 
(HDACs) and histone acetylation in cultured cells (7, 8). Despite this, 
the roles of HDACs during developmental metabolic transitions re-
main undefined.
RESULTS
Among mammalian HDACs, paralogous Hdac1 and Hdac2 have the 
highest activity toward nucleosome substrates, enabling chromatin 
remodeling (9). To investigate the role of Hdac1 and Hdac2 in early 
cardiac metabolism, we genetically ablated murine Hdac1/Hdac2 using 
Nkx2.5IRES-Cre (10), Hdac1Flox, and Hdac2Flox (11) (Nkx2.5;1KO2KO) 
alleles. Complete loss of Hdac1/Hdac2 was observed in the developing 
heart starting at embryonic day 10.5 (E10.5) (fig. S1). Nkx2.5;1KO2KO 
embryos were comparable in size at E10.5; however, these embryos 
exhibited complete embryonic lethality by E11.5 (Fig. 1, A to C). 
We observed increased light transmission through the primitive 
heart tube (PHT) in E10.5 Nkx2.5;1KO2KO embryos, suggesting 
defective cardiogenesis (Fig. 1C). Morphologic staining revealed a 
thinner myocardium and reduced eosinophilic cytoplasm in E10.5 
Nkx2.5;1KO2KO cardiomyocytes (Fig. 1, D and E) without major changes 
in proliferation, apoptosis, or cell number (not shown). Transmission 
electron micrographs (TEMs) of E10.5 PHTs showed Nkx2.5;1KO2KO 
cardiomyocytes had accumulations of cytoplasmic lipid droplets, a 
fragmented contractile network, and abnormal mitochondria con-
sistent with failure to initiate OXPHOS (Fig. 1, F and G).
To define transcriptional changes, we performed Affymetrix 
Clariom D Pico assays on E10.5 Nkx2.5;1KO2KO PHTs. Among 8127 
differentially regulated transcripts with NCBI (National Center 
for Biotechnology Information) identifiers, 52% were reduced in 
Nkx2.5;1KO2KO, while 48% were increased relative to controls (Fig. 2, 
A and B). Protein ANalysis THrough Evolutionary Relationships 
(PANTHER) analysis showed enrichment in mitochondrial metab-
olism categories, such as tricarboxylic acid cycle (TCA), adenosine 
5′-triphosphate (ATP) formation, cristae formation, and complex I 
biogenesis without corollary upstream changes (Fig. 2C and fig. S2) 
(12). Despite relatively equal numbers of up-/down-regulated tran-
scripts, enriched categories contained almost exclusively down-regulated 
genes, suggesting that Hdac1/Hdac2 facilitates metabolic gene expression 
(Fig. 2C). We found corresponding reductions in mitochondrial DNA 
content and protein expression in E10.5 Nkx2.5;1KO2KO PHTs (Fig. 2, 
D and E). Similarly, reduced protein expression of critical mitochondrial 
proteins in neonatal 1KO2KO hearts with normal contractile protein 
network and reduced oxygen consumption in 1KO2KO cardiomyocytes 
confirm requirement of Hdac1 and Hdac2 for mitochondrial func-
tion (fig. S3, A to C). There is a strong interrelationship between 
cardiac bioenergetics and structural development. Transition from 
early anaerobic fetal metabolism to OXPHOS, facilitated by mito-
chondrial permeability transition pore (mPTP) closure between 
E9.5 and E11.5, is necessary and sufficient to drive cardiomyocyte 
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Fig. 1. Loss of Hdac1/Hdac2 within Nkx2.5IRES-Cre+ cells causes defective cardiogenesis and complete embryonic lethality. (A) Nkx2.5IRES-Cre;1F+2F+ was crossed with 
1FF2FF, and samples were recovered at various time points. aThree embryos dying. *P < 0.05; ns, not significant. (B) Nkx2.5;1KO2KO and 1FF2FF embryos at embryonic day 11.5 
(E11.5) (arrows, pooled blood). (C) Nkx2.5;1Het2Het;R26R-LacZ−/+ and Nkx2.5;1KO2KO;R26R-LacZ−/+ E10.5 embryos. (D) Hematoxylin and eosin–stained Nkx2.5;1Het2Het and 
Nkx2.5;1KO2KO E10.5 sagittal sections at atrioventricular canal (AVC) level (arrows, eosinophilic cytoplasm; bars, compact thickness). (E) Compact myocardial thickness in 
control and Nkx2.5;1KO2KO E10.5 primitive ventricles (PrVs). (F) Transmission electron micrographs (TEMs) of Nkx2.5;1KO2KO and 1FF2FF E10.5 cardiomyocytes (blue, contractile 
fibers; orange, cytoplasmic lipid droplets). (G) TEM of Nkx2.5;1KO2KO and 1FF2FF E10.5 cardiomyocyte mitochondrial structure, density, and size.
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Fig. 2. Primitive heart tubes lacking Hdac1 and Hdac2 exhibit down-regulation of metabolic gene programs. (A) Analysis of differentially regulated transcripts at 
various levels. (B) Heatmap of identified, differentially regulated transcripts grouped by Spearman clustering. (C) Top enriched PANTHER reactome terms (gold) with parent 
categories (green). Doughnuts show distribution of transcript changes. (D) Mitochondrial DNA (mtDNA) quantification relative to nuclear DNA (nDNA) in Nkx2.5;1KO2KO 
and 1FF2FF E10.5 PHTs. (E) Atp5a, Slc25a24, and Got2 staining on Nkx2.5;1KO2KO and 1FF2FF E10.5 sagittal sections at AVC level with Hoechst nuclear counterstain. Grayscale 
images are unedited. tRNA, transfer RNA.
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Fig. 3. Hdac1 and Hdac2 suppress cryptic transcription during cardiogenesis. (A) Distribution of differentially regulated transcripts (black), differentially regulated 
transcripts with a cryptic signature (red), and unchanged transcripts (gray) in Nkx2.5;1KO2KO compared with 1FF2FF E10.5 PHTs. (B and C) Normalized exon-level expression 
values for citrate synthase (CS; B) and Ndufb9 (C) in Nkx2.5;1KO2KO and 1FF2FF E10.5 PHTs. (D to G) PANTHER analysis (D and E) and Gene Set Enrichment Analysis (GSEA) 
(F and G) of differentially regulated, identified cryptic transcripts. (H and I) 5′ rapid amplification of complementary DNA (cDNA) ends (5′RACE) for CS (F) and Ndufb9 (E). 
Left: 5′RACE products (black, canonical; blue/green, alternative). Right: Alignment of sequenced products. TSSC, canonical TSS; TSSA#, alternative TSS; ns, not significant; 
FWER, Family-wise error rate; Pol II, polymerase II.
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Fig. 4. Hdac1 and Hdac2 cooperate to suppress cryptic transcription through deacetylation of key histone residues at alternative transcription start sites during 
mammalian cardiogenesis. (A and B) H3K23ac (A) and H4K16 (B) staining on Nkx2.5;1KO2KO and 1FF2FF E10.5 sagittal sections at AVC level with cardiac troponin (cTnT) 
and Hoechst counterstains. Grayscale images are unedited. (C to E) ChIP-qPCR showing relative enrichment (TSSA versus TSSC) of Hdac1and Hdac2 at CS TSSA (C) and 
Ndufb9 TSSA1 (D), TSSA2 (E), normalized to immunoglobulin G (IgG). (F to I) H3K36me3 (E), H3K23ac (F), H3K14ac (G), and H4K16ac (H) ChIP-qPCR showing relative enrichment 
over TSSC/TSSAs for CS and Ndufb9 in Nkx2.5;1KO2KO and 1FF2FF E10.5 PHTs. (J) Hdac1/Hdac2 controls cardiomyocyte development at a critical metabolic checkpoint. CHD, 
chromodomain containing subunit. WT, wild type.
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differentiation (13). E10.5 is a metabolic checkpoint with disruptions 
of cardiac bioenergetics associated with early embryonic lethality (12, 14). 
Consequently, we propose that loss of Hdac1/Hdac2 disrupts the 
anaerobic to OXPHOS switch, arresting cardiogenesis at E10.5.
We next determined how Hdac1/Hdac2 cooperates to facilitate 
metabolic transcriptional programs during cardiogenesis. Examina-
tion of exon-level expression data revealed a transcriptional signature 
of lowered initiation at canonical transcription start sites (TSSCs) 
but increased initiation from downstream, alternative transcription 
start sites (TSSAs) specifically in down-regulated metabolic transcripts 
(Fig. 3, A to G, and fig. S4, A and B). Highlighting two critical tran-
scripts, citrate synthase (CS) and NADH:ubiquinone oxioreductase 
subunit B9 (Ndufb9), we looked for evidence of noncanonical tran-
scripts using 5′ rapid amplification of complementary DNA (cDNA) 
ends (5′RACE). We identified strong control bands corresponding 
to canonical transcripts for both CS and Ndufb9 (Fig. 3, H and I). 
No canonical transcript was found for CS following Hdac1/Hdac2 
ablation, instead a truncated transcript originating from a distal TSSA 
was identified (Fig. 3H). Two alternative Ndufb9 transcripts were 
identified, originating from two distinct TSSAs. We observed de-
creased intensity of the canonical and second alternative Ndufb9 
transcripts in E10.5 Nkx2.5;1KO2KO hearts (Fig. 3I). To confirm our 
findings, we quantified abundance of early exon junctions relative 
to late exon junctions, finding a significantly reduced ratio of early 
to late exon junction expression in Nkx2.5;1KO2KOs consistent with 
reduced canonical and increased alternative transcription (fig. S4C). 
Together, these results suggest that Hdac1/Hdac2 represses cryptic 
initiation of transcription from intragenic TSSAs to facilitate the 
anaerobic to OXPHOS switch during early cardiac development.
Transcription-induced histone modifications at an alternative 
transcription start sites can antagonize the permissive environment 
of proximal promoter and enhancer elements, attenuating gene ex-
pression from canonical transcription start site (15, 16). Supporting 
this model, several covalent histone modifications have been associated 
with cryptic transcription including H3K14ac, H3K23ac, H4K16ac, 
and H3K36me3 (17). Embryonic and postnatal hearts lacking Hdac1 
and Hdac2 exhibited increased numbers of H3K23ac and H4K16ac 
foci in cardiomyocyte nuclei (Fig. 4, A and B, and fig. S5, A and B). 
Similarly, we observed enrichment of H3K36me3, H3K23ac, H3K14ac, 
and H4K16ac at the TSSAs of CS and Ndufb9, consistent with cryptic 
initiation of transcription (Fig. 4, C to F, and fig. S5C). Hdac1 and 
Hdac2 occupancy at the TSSA of CS, TSSA1 of Ndufb9, and TSSA2 of 
Ndufb9 in E10.5 PHTs (Fig. 4, G to I) suggests that Hdac1/Hdac2 
cooperatively and directly suppresses activating histone marks 
throughout actively transcribed gene bodies, restricting transcription 
to defined TSSCs (Fig. 4J).
DISCUSSION
To our knowledge, this report is the first link between HDACs and 
cryptic transcription during vertebrate development and the first to 
link cryptic transcription and mitochondrial function. Cryptic tran-
scription is observed in lower organisms and mammalian cell lines, 
yet no reports describe cryptic transcription in a vertebrate system 
(15, 17). In yeast, cryptic transcription is regulated by Set2 and Rpd3s 
(18–20). Set2, an H3K36 methyltransferase, is recruited to active loci by 
RNA polymerase II, causing accumulation of H3K36 trimethylation. 
H3K36me3 recruits Rpd3s (homologous to the Sin3 complex) through 
Eaf3’s chromodomain to deacetylate residues including H3K23, H3K14, 
and H4K16 (15, 17, 18, 21). This axis restores basal chromatin con-
formations following transcription, preventing cryptic initiation of 
transcription. HDAC or DNA methyl transferase inhibition in cul-
tured cells increases cryptic transcription across the genome, suggest-
ing, much like inappropriately condensed chromatin can disrupt 
initiation, cryptic transcription results from inappropriately open 
chromatin (16, 17). Open conformations expose noncanonical promoter 
and enhancer regions, driving the synthesis of noncoding mRNA 
transcripts and disrupting canonical transcription. Cumulatively, 
these results suggest that chromatin homeostasis is crucial for 
ordered transcription.
Here, we demonstrate that mammalian Rpd3 homologs, Hdac1/
Hdac2, redundantly suppress cryptic initiation of transcription during 
mammalian cardiogenesis. Loss of Hdac1/Hdac2 in developing 
murine hearts promotes cryptic transcription at metabolic loci, 
including CS and Ndufb9, during a critical period of bioenergetic 
maturation. Mechanistically, we identified accumulation of H3K36 
trimethylation and H3K23/H3K14/H4K16 acetylation, consistent 
with inappropriately open chromatin at the TSSAs of CS and Ndufb9. 
This suggests that Hdac1/Hdac2, much like Rpd3, suppresses cryptic 
transcription by restoring basal chromatin accessibility following 
transcription (Fig. 4J).
Our study reconciles prior observations that HDACs, classically 
viewed as chromatin condensers and transcriptional repressors, ex-
hibit residency at actively transcribed loci during development (22). 
In addition, transcriptome analysis following Hdac1/Hdac2 inhibition/
inactivation reveals differential gene expression consistent with 
HDACs having both permissive and repressive roles. We show that 
Hdac1/Hdac2 restores basal chromatin conformation of active loci 
by pruning activating histone marks deposited during transcription. 
Further, Hdac1/Hdac2 cooperatively regulates genome-wide levels 
of H3K23 and H4K16 acetylation, two marks associated with cryptic 
transcription, with loss of Hdac1/Hdac2 increasing cryptic transcrip-
tion. These data, and previous literature reports, establish Hdac1/
Hdac2 with duals roles, first their classically defined repressive role 
and now novel function as repressors of cryptic transcription.
Our study highlights the integration of epigenetics, transcriptional 
fidelity, and metabolism during murine cardiogenesis. Early in 
development, the PHT sustains contraction through anaerobic 
metabolism (1, 12). Between E9.5 and E11.5, the mPTP closes, 
establishing an electrochemical gradient for oxidative energy pro-
duction (3, 13). Failure is associated with lethality, positioning E10.5 
as a checkpoint of cardiac bioenergetic maturation (12, 14). Abnormally 
thinned myocardium, down-regulated metabolic genes, and lethality 
between E10.5 and E11.5 in Nkx2.5;1KO2KO suggest a failure of this 
checkpoint. In addition, cytoplasmic accumulations of lipid droplets 
and abnormal mitochondrial morphology are consistent with a failed 
transition. Mechanistically, Hdac1/Hdac2 maintains transcriptional 
fidelity of gene programs required for the mitochondrial biogenesis, 
including all complexes of the electron transport chain. Overall, this 
study identifies Hdac1/Hdac2 as regulators of cardiac bioenergetic 
maturity, canonical initiation, and cryptic transcription during 
mammalian cardiogenesis.
MATERIALS AND METHODS
Animals
Nkx2.5IRES-Cre (stock#: 024637), ROSAmT/mG (stock#: 007576), 
MHCMerCreMer (stock#: 005657), and R26RLacZ (stock#: 003474) were 
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obtained from the Jackson laboratory. Hdac1Flox, Hdac2Flox, and 
CMVCre(ERT2) mice used in this study have been previously described 
(11). All animal protocols were approved by the University of 
Massachusetts Medical School Institutional Animal Care and Use 
Committee. Embryonic samples were generated via timed mating. 
Following the identification of a vaginal plug, pregnant females were 
isolated and euthanized, and embryos were dissected at the appropriate 
embryonic time point (ranging from 9.5 to 11.5 days after fertilization). 
Mice were then separated into double knockout and control groups 
according to their genotype and developmental stage.
Antibodies and reagents
The following antibodies were used in this study: Hdac1 (Abcam), 
Hdac2 (Thermo-Fisher), cardiac troponin [cTnT; Developmental 
Studies Hybridoma Bank (DSHB)], MYH (Santa Cruz), ATP5A 
(Abcam), SLC25A24 (DSHB), GOT2 (DSHB), H3K36me3 (Abcam), 
H3K23ac (Abcam), H3K14ac (Active Motif), H4K16ac (Abcam), RNA 
polymerase II (Epigentek), and nonimmune immunoglobulin G (IgG; 
Epigentek). Eosin Y and Harris modified hematoxylin were obtained 
from Fisher, while X-gal was purchased from 5-Prime. Vectashield 
permanent mounting medium, Vectashield fluorescent mounting 
medium, Vectashield Elite ABC reagent kit, Vector TrueVIEW 
Autofluorescence Quenching Kit, and DAB Peroxidase Substrate 
kit were purchased from Vector Labs. ProLong Glass Antifade 
Mounting Medium was purchased from Thermo Fisher Scientific. 
Donkey serum and horse serum were obtained from Sigma. RNeasy 
Plus Micro, QIAquick Gel Extraction, and DNeasy Blood and Tissue 
kits were obtained from Qiagen. Chromaflash High Sensitivity ChIP 
Kit was from Epigentek. SMARTer RACE 5′/3′ kit was from Takara Bio.
Histology
Tissue samples were collected, fixed in 4% paraformaldehyde in 
1× phosphate-buffered saline (PBS) at 4°C overnight, dehydrated 
through an ethanol gradient, embedded in paraffin, and sectioned 
at 8-m thickness on a Leica fully motorized rotary microtome.
Imaging
Images of dissected embryos were captured on a Leica Mz10 F fluo-
rescence stereomicroscopy via a 0.7× C-mount, Achromat 1.0 x 
90–mm objective, SOLA light engine (Lumencore), and DS-Fi1 color 
camera (Nikon) through NIS-Elements Basic Research Software 
(Nikon). Images of stained sections were captures using a Nikon 
Eclipse 80i microscope via CFI Plan Fluro 4×/10×/20×/40× objective 
lenses, SOLA light engine, DS-Fi1 color camera, and NIS-Elements 
Basic Research Software. Confocal microscopy images were acquired 
using a Leica TCS SP5 II Laser Scanning Confocal microscope. Alexa 
Fluor 488 and 568 were simultaneously excited at 488 and 561 nm with 
confocal lasers, respectively. Emissions were split by an Main Beam 
Splitter 488/561/633 and captured with two detection ranges (ch1, 
493 to 536 nm; ch2, 576 to 685 nm). For nuclear staining, Hoechst was 
excited using a Chameleon Ti:sapphire pulse laser (755 nm) (Coherent 
Inc.) and was emission detected at 387 to 486 nm. Image stacks of 
vertical projections were assembled using ImageJ software (National 
Institutes of Health). Additional confocal images were acquired with 
a Zeiss LSM800 airyscan confocal scanning microscope equipped with 
a solid state laser module with 405-, 488-, 561-, and 640-nm beam 
splitter, Plan-Apochromat objectives with DIC (63×/1.4 oil, 20×/0.8, 
and 10×/0.45), and Zeiss’s Zen 2.5 imaging software. All analyses were 
performed on at least three biologically independent samples (n = 3).
Hematoxylin and eosin staining
Staining was performed via deparafanizing sections in xylenes, re-
hydrating with an ethanol gradient, a 30-s stain with 30% Harris 
modified hematoxylin (in diH2O) followed by a 30-s counterstain 
with eosin Y. Stained slides were rinsed and then dehydrated through 
an ethanol gradient, cleared with xylenes, and mounted using 
Vectashield permanent mounting medium. All analyses were per-
formed on at least three biologically independent samples (n = 3).
LacZ (-gal) staining
Samples for LacZ (-gal) staining were quickly dissected in cold PBS 
and fixed in 2% paraformaldehyde for 30 min at 4°C. Samples were 
then washed in PBS at room temperature and stained overnight in 
staining solution (5 mM potassium ferricyanide, 5 mM potassium 
ferrocyanide, 2 mM MgCl2, 0.01% deoxycholic acid, 0.04% NP-40, 
0.1% X-gal, in 1× PBS) in the dark at 37°C or until staining developed. 
Samples were then washed in 1× PBS and fixed overnight in 4% 
paraformaldehyde in PBS at 4°C. All analyses were performed on at 
least three biologically independent samples (n = 3).
Immunohistochemistry
Selected sections were deparaffinized in xylenes, rehydrated through 
an ethanol gradient, pretreated using the Aptum Antigen Retriever 
2100 and Aptum R-buffer A or sodium citrate buffer (pH 6.0). Sec-
tions for immunofluorescence staining were blocked with 10% donkey 
serum/0.3% Triton X-100 in PBS for 1 hour at room temperature. 
Sections were then washed with PBS and probed with primary anti-
body (in 10% donkey serum in PBS) overnight at 4°C. Subsequently, 
slides were washed with PBS and incubated with Alexa Fluor 
488/546/568–conjugated secondary antibodies (1:500) and Hoechst 
nuclear counterstain (1:1000) at room temperature for 1 hour. Follow-
ing incubation, slides were rinsed, quenched with Vector TrueVIEW 
Autofluroescence quenching kit according to the manufacturer’s 
guidelines, rinsed again, and mounted with either Vectashield 
fluorescent mounting medium or ProLong Glass Antifade mountant. 
All analyses were performed on at least three biologically independent 
samples (n = 3).
Morphometric analysis
Quantitative morphologic analysis was performed using ImageJ 
software to measure and record anatomical features of interest. 
Primitive ventricular thickness was estimated by comparing the 
average of four serial measurements on each section of interest across 
10 independent biologic samples from both genotypes of interest 
(n = 10). Raw pixel values were converted to a micron scale according 
to a conversion factor related to the microscope objective/imaging 
parameters used.
Quantification of immunohistochemistry/immunofluorescence
Cell counting was performed using ImageJ software to measure and 
record staining points of interest. The ImageJ Cell Counter plugin 
was used to record the total number of cardiomyocyte nuclei (cTnT+ 
or MYH+) in each section and the number of double-positive nuclei 
(cTnT+ or MYH+ AND CC3+ or PHH3+). The number of double- 
positive nuclei per 100 cardiomyocyte nuclei is presented as either 
apoptotic index (CC3) or proliferative index (PHH3). All analyses 
were performed with 13 to 16 biologically independent samples (n = 13 
to 16). Control genotypes include 1++2++, 1FF2FF, Nkx2.5;1Het2Het, 
and Nkx2.5;1Het2KO.
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Transcriptome analysis
PHTs were isolated from E10.5 mouse embryos and snap frozen in 
liquid nitrogen before being stored at −80°C. RNA was extracted from 
pools of 20 1FF2FF and Nkx1.5;1KO2KO hearts using a Qiagen RNeasy 
Plus Micro kit (n = 20). The Clariom D Pico Assay (Affymetrix) was 
performed in triplicate (n = 3) from pooled samples of 20 E10.5 PHTs 
by the University of Massachusetts Genomics Core Facility. Raw data 
were analyzed using the Affymetrix Transcriptome Analysis Console 
with a significant cutoff of false discovery rate (FDR) <0.05. Data were 
further analyzed using Database for Annotation, Visualization and 
Integrated Discovery (DAVID) Functional Annotations Bioinformatics 
Microarray Analysis, PANTHER Gene List Analysis, and Broad 
Institute Gene Set Enrichment Analysis (GSEA) using default settings. 
Spearman hierarchical clustering was performed to visualize inter-
relationships within our data. Lists of enriched ontologic categories were 
generated and used to create heatmaps, enrichment plots, and doughnut 
charts in GraphPad Prism. Heatmaps were generated using GraphPad 
Prism. Relative transcript expression is reported as the log-transformed 
expression value normalized to the median across all six samples.
Transmission electron microscopy
PHTs from E10.5 mouse embryos were dissected in cold 1× PBS and 
immediately immersed in 2.5% glutaraldehyde in 0.1 M sodium 
cacodylate buffer (pH 7.2) and fixed overnight at 4°C. Samples were 
processed and analyzed at the University of Massachusetts Medical 
School Core Electron Microscopy Facility according to standard 
procedures. Briefly, after fixation, the samples were rinsed three times 
in the same fixation buffer and postfixed with 1% osmium tetroxide 
for 1 hour at room temperature. Samples were then washed three times 
with diH2O for 20 min and dehydrated through a graded ethanol 
series of 20% increments before two changes in 100% ethanol. The 
samples were then infiltrated first with two changes of 100% propylene 
oxide and then with 50/50% propylene oxide/SPI-Pon 812 resin. 
The following day, six changes of fresh 100% SPI-Pon 812 resin were 
performed before samples were polymerized at 68°C in flat embedding 
molds. The samples were then reoriented as to obtain cross sections 
of the heart tubes, and 1-m sections were cut and stained with 
toluidine blue to confirm orientation. Approximately 70-nm sections 
of this area were collected and placed on copper support grids and 
contrasted with lead citrate and uranyl acetate. Sections were then 
examined using a FEI Tecnai 12 TEM with 120-kV accelerating 
voltage, and images were captured using a Gatan TEM charge-coupled 
device camera. All analyses were performed in triplicate (n = 3).
Mitochondrial DNA/nuclear DNA Quantification
PHTs were isolated from E10.5 mouse embryos and snap frozen in 
liquid nitrogen before being stored at −80°C. Total DNA was extracted 
from a pool of five biologically independent 1FF2FF and Nkx2.5;1KO2KO 
hearts (n = 5) using a Qiagen DNeasy Blood and Tissue kit (n = 5). 
Relative levels of mitochondrial (mtDNA) and nuclear DNA (nDNA) 
were quantified by quantitative polymerase chain reaction (PCR) 
using SYBR Green Master Mix and previously reported primers 
(below). mtDNA levels were normalized to nDNA levels and then 
compared between 1FF2FF and Nkx2.5;1KO2KO samples. Primer sequences 
are included in the Supplementary Materials.
Rapid amplification of cDNA ends
5′RACE experiments were performed using a Takara Bio SMARTer 
5′RACE and 3′RACE Kit according to manufacturer guidelines. 
Briefly, PHTs were isolated from E10.5 mouse embryos and snap 
frozen in liquid nitrogen before being stored at −80°C. 1FF2FF and 
Nkx2.5;1KO2KO total RNA was isolated using a Qiagen RNeasy Plus 
Micro Kit from pools of three biologically independent samples 
(n = 3), and first-strand cDNA was synthesized using reagents and 
protocols provided by the kit. Using primers complementary to 
sequences in distal exons of key metabolic genes (below) and reagents 
provided in the kit, 5′RACE was performed. Products were resolved 
in a 1% tris-acetate-EDTA (TAE)/ethidium bromide gel, extracted 
using a QIAquick Gel Extraction Kit (Qiagen), and sequenced 
(Eurofins Genomics). Specificity and alignment of sequences were 
determined using MacVector. Primer sequences are included in the 
Supplementary Materials.
Chromatin immunoprecipitation quantitative PCR
Chromatin immunoprecipitation quantitative PCR (ChIP-qPCR) 
experiments were performed using an Epigentek ChromaFlash High 
Sensitivity ChIP Kit (Epigentek) according to the manufacturer’s 
guidelines. Briefly, 1+/+2+/+ (WT) and Nkx2.5;1KO2KO (DKO) PHTs 
were isolated from E10.5 mouse embryos and snap frozen in liquid 
nitrogen before storage at −80°C. Biologically independent samples 
were pooled (n = 7 to 10), briefly fixed in 1% formaldehyde in 1× 
PBS at room temperature for 30 min before being quenched with 
glycine for 5 min, and washed with 1× PBS. Chromatin fragmentation 
was performed in lysis buffer (Epigentek) using a Covaris M220 
(two cycles of the following: peak power, 50; duty factor, 20; cycles/
burst, 200; duration, 3 min). Proteins were immunoprecipitated 
from 0.7 to 2 g of chromatin in ChIP buffer using Hdac1, Hdac2, 
H3K36me3, H3K23ac, H3K14ac, H4K16ac, RNA polymerase II, and 
nonimmune IgG antibodies on an orbital shaker (100 rpm) at room 
temperature for 1 hour before being transferred to 4°C overnight. 
Immunoprecipitated antibody-chromatin complexes were washed 
four times with the provided wash buffer, treated with RNase A, 
proteinase K, and eluted using elution buffer. DNA was further 
purified using the included purification columns and protocol. Using 
purified immunoprecipitated DNA, enrichment of the targets at 
various locations were measured using qPCR with SYBR Green 
Master Mix and the primers. Primer sequences are included in the 
Supplementary Materials.
Quantitative reverse transcription PCR
PHTs were isolated from E10.5 mouse embryos and snap frozen in 
liquid nitrogen before being stored at −80°C. Total RNA was isolated 
from pools of 10 biologically independent 1FF2FF and Nkx2.5;1KO2KO 
samples (n = 10) using a Qiagen RNeasy Plus Micro kit, quantified, 
and identical amounts of cDNA were generated via reverse transcrip-
tion using iScript reverse transcription supermix (Bio-Rad) according 
to the manufacturer’s guidelines. Transcription expression was mea-
sured by qPCR using SYBR Green Master Mix. Relative expression 
levels were calculated using the ∆∆Ct method using glyceraldehyde- 
3-phosphate dehydrogenase (Gapdh) (unchanged in our transcriptome 
analysis) as a reference transcript. Primer sequences are included in 
the Supplementary Materials.
Cardiomyocyte isolation
Cardiomyocytes were prepared from P0 1FF;2FF hearts of approxi-
mately 10 mouse pups. Ventricular tissues were predigested in trypsin 
(0.5 mg/ml; Sigma)–Hank’s balanced salt solution without Ca2+ 
at 4°C for 30 min with constant shaking. Cells were dissociated by 
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four rounds of 4-min digestion with purified type II collagenase 
(Gibco) in Hank’s balanced salt solution at 37°C. Fibroblasts were 
removed from the cell suspension by two rounds of 1-hour differ-
ential plating at 37°C in Dulbecco’s modified Eagle medium/M199 
(4:1 ratio) medium containing 10% horse serum, 5% fetal bovine 
serum, penicillin (100 U/ml), streptomycin (100 g/ml), and Hepes 
(25 mM) in the presence of 5% CO2. Myocytes were cultured on 
fibronectin-coated (Sigma) tissue culture plates.
Oxygen consumption rate
Oxygen consumption was measured using a Seahorse XFe96 Analyzer 
at 25°C according to the manufacturer’s protocol. In brief, isolated 
cardiomyocytes from P0 1FF2FF hearts were equally plated into each 
well of a 96-well microplate containing 200 l of M9 buffer and 
infected with control or Cre-expressing viral media supplemented 
with polybrene reagent (10 g/ml). After 48 hours, basal respiration 
was measured for a total of 30 min, in 6-min intervals that included 
a 2-min mix, a 2-min time delay, and a 2-min measurement.
CUT&RUN
CUT&RUN was performed as previously described with the follow-
ing modifications (23–25). Nuclei were isolated from 24 control and 
Nkx2.5; 1FF;2FF E10.5 heart tubes. Briefly, frozen tissues were disso-
ciated with a Dounce homogenizer using swelling buffer (10 mM 
Hepes, 2 mM MgCl2, 3 mM CaCl2) followed by lysis buffer (10 mM 
Hepes, 2 mM MgCl2, 3 mM CaCl2, 10% glycerol, 1% IGEPAL). The 
isolated nuclei were washed twice in PBS and resuspended in wash 
buffer (20 mM Hepes, pH 7.5, 150 mM NaCl, 0.5 mM spermidine, 
protease inhibitors). Concanavalin A–coated beads were washed 
twice in 1 ml of binding buffer (20 mM Hepes-KOH, pH 7.9, 10 mM 
KCl, 1 mM CaCl2, 1 mM MnCl2) and resuspended in binding buffer 
equal to the volume of bead slurry (10 l per sample) before they 
were added to the cells. Bead-bound cells were incubated with 6 g 
of H4K16ac antibody (Abcam) and IgG (Abcam) in 150 l of anti-
body buffer (wash buffer, 2 mM EDTA) overnight at 4°C. Protein 
A–micrococcal nuclease was added at a concentration of 700 ng/ml 
in wash buffer and incubated at 4°C for 1 hour. Chromatin cleavage 
was initiated after incubation with 1 ml of low-salt rinse buffer (0.5 mM 
spermidine, 20 mM Hepes, pH 7.5) using 10 mM CaCl2-containing 
incubation buffer [10 mM CaCl2, 3.5 mM Hepes, pH 7.5) at 0°C for 
30 min. Digestion was stopped with the addition of 200 l of stop 
buffer [200 mM NaCl, 20 mM EDTA, 4 mM EGTA, RNase A 
(50 g/ml), glycogen (40 g/ml), yeast spike-in DNA (10 pg/ml)]. 
Digested fragments were released by incubating at 37°C for 30 min. 
DNA was purified using phenol/chloroform extraction followed by 
ethanol precipitation. Cut&Run library preparation included Illumina 
paired-end adaptor ligation and amplification. In all cases, library 
quality and concentration were determined using Fragment Analyzer 
(UMASS Medical School Deep Sequencing Core). Deep sequencing 
of H4K16ac libraries were performed by UMASS Medical School 
Deep Sequencing Core.
Cryptic event identification and volcano plot
We considered all transcripts with a fold change FDR <0.05 and 
determined the presence of alternative transcripts from intragenic 
transcription start sites (cryptic event) by comparing the exon-level 
probe signals in DKO and Cntrl transcripts. A cryptic event was called 
when a single transcript had a significantly decreased expression of 
the first probe and no difference between a later probe in DKO com-
pared to Cntrl. We hypothesized that this transcriptional signature 
of distal normalization was consistent with intragenic transcript 
generation. Using this list of transcripts with cryptic events, we created 
a volcano plot of log2(fold change) versus −log2(FDR) and performed 
gene ontology using PANTHER Gene List Analysis.
Statistical analysis
Data are shown as means with error bars representing the SD 
[mean(SD)]. Significant differences between means were determined 
using an unpaired two-tailed Student’s t test, the Holm-Sidak method, 
or 2 test. The level of significance () was set at 0.05 for all analyses. 
Per GraphPad Prism standard annotation: ns, P > 0.05, *P < 0.05; 
**P < 0.01; ***P < 0.001; ****P < 0.0001. Analysis was performed 
using either Microsoft Excel or GraphPad Prism 8.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/15/eaax5150/DC1
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